ICD-10 Coding for Parkinsonism(F02.81, F02.81U, G21.11)
Comprehensive guide to ICD-10 coding for Parkinsonism, including primary and secondary codes, documentation requirements, and common pitfalls.
Complete code families applicable to Parkinsonism
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| G20 | Parkinson's disease | Use for idiopathic Parkinson's disease confirmed by clinical evaluation and response to treatment. |
|
| G21.11 | Drug-induced secondary parkinsonism | Use for parkinsonism caused by neuroleptic drugs, confirmed by clinical history. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutParkinsonism
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Parkinsonism.
Insufficient documentation of symptoms.
Impact
Clinical: Misdiagnosis risk, Regulatory: Coding audits, Financial: Denied claims
Mitigation
Use comprehensive assessment tools., Regularly update patient records.
Using G20 for secondary parkinsonism
Impact
Reimbursement: Incorrect DRG assignment, Compliance: Non-compliance with coding guidelines, Data Quality: Inaccurate clinical data representation
Mitigation
Use G21 codes for secondary causes with appropriate T codes.
Not adding dementia code when present
Impact
Reimbursement: Potential underpayment, Compliance: Incomplete coding, Data Quality: Inaccurate depiction of patient condition
Mitigation
Add F02.81 for dementia with behavioral disturbance.
Documentation of idiopathic vs. secondary parkinsonism
Impact
Failure to differentiate can lead to incorrect coding.
Mitigation
Ensure thorough clinical evaluation and documentation.